Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen-activated protein kinase in vitro - PubMed (original) (raw)
. 1995 Jun 2;270(22):13341-7.
doi: 10.1074/jbc.270.22.13341.
Affiliations
- PMID: 7768935
- DOI: 10.1074/jbc.270.22.13341
Free article
Phosphorylation of tristetraprolin, a potential zinc finger transcription factor, by mitogen stimulation in intact cells and by mitogen-activated protein kinase in vitro
G A Taylor et al. J Biol Chem. 1995.
Free article
Abstract
Tristetraprolin (TTP) is a potential transcription factor that contains three PPPPG repeats and two putative CCCH zinc fingers. TTP is encoded by the early response gene Zfp-36, which is highly expressed in response to growth factors and in several hematopoietic cell lines. In the present studies, we investigated the possibility that TTP is phosphorylated in intact cells. In NIH/3T3 cells that were made to overexpress TTP constitutively, we found that the protein was phosphorylated on serine residues, and that this phosphorylation was rapidly (within 10 min) stimulated by several mitogens. In cell-free assays, recombinant mouse TTP was a substrate for the mitogen-activated protein (MAP) kinase. By a combination of protease digestion experiments and site-directed mutagenesis strategies, we found that serine 220 was phosphorylated by p42 MAP kinase in vitro. Expression of mutant TTP in fibroblasts confirmed that serine 220 was one of the major, mitogen-stimulated phosphorylation sites on the protein in intact cells. These results suggest that TTP may be phosphorylated by MAP kinases in vivo and that this phosphorylation may regulate its function.
Similar articles
- Mitogens stimulate the rapid nuclear to cytosolic translocation of tristetraprolin, a potential zinc-finger transcription factor.
Taylor GA, Thompson MJ, Lai WS, Blackshear PJ. Taylor GA, et al. Mol Endocrinol. 1996 Feb;10(2):140-6. doi: 10.1210/mend.10.2.8825554. Mol Endocrinol. 1996. PMID: 8825554 - MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding.
Chrestensen CA, Schroeder MJ, Shabanowitz J, Hunt DF, Pelo JW, Worthington MT, Sturgill TW. Chrestensen CA, et al. J Biol Chem. 2004 Mar 12;279(11):10176-84. doi: 10.1074/jbc.M310486200. Epub 2003 Dec 19. J Biol Chem. 2004. PMID: 14688255 - Promoter analysis of Zfp-36, the mitogen-inducible gene encoding the zinc finger protein tristetraprolin.
Lai WS, Thompson MJ, Taylor GA, Liu Y, Blackshear PJ. Lai WS, et al. J Biol Chem. 1995 Oct 20;270(42):25266-72. doi: 10.1074/jbc.270.42.25266. J Biol Chem. 1995. PMID: 7559666 - Phosphorylation site analysis of the anti-inflammatory and mRNA-destabilizing protein tristetraprolin.
Cao H, Deterding LJ, Blackshear PJ. Cao H, et al. Expert Rev Proteomics. 2007 Dec;4(6):711-26. doi: 10.1586/14789450.4.6.711. Expert Rev Proteomics. 2007. PMID: 18067411 Free PMC article. Review. - The mitogen-activated protein kinase signal transduction pathway.
Davis RJ. Davis RJ. J Biol Chem. 1993 Jul 15;268(20):14553-6. J Biol Chem. 1993. PMID: 8325833 Review. No abstract available.
Cited by
- RNA binding proteins as regulators of immune cell biology.
Newman R, McHugh J, Turner M. Newman R, et al. Clin Exp Immunol. 2016 Jan;183(1):37-49. doi: 10.1111/cei.12684. Epub 2015 Sep 11. Clin Exp Immunol. 2016. PMID: 26201441 Free PMC article. Review. - The role of tristetraprolin in cancer and inflammation.
Sanduja S, Blanco FF, Young LE, Kaza V, Dixon DA. Sanduja S, et al. Front Biosci (Landmark Ed). 2012 Jan 1;17(1):174-88. doi: 10.2741/3920. Front Biosci (Landmark Ed). 2012. PMID: 22201737 Free PMC article. Review. - Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway.
Carballo E, Cao H, Lai WS, Kennington EA, Campbell D, Blackshear PJ. Carballo E, et al. J Biol Chem. 2001 Nov 9;276(45):42580-7. doi: 10.1074/jbc.M104953200. Epub 2001 Sep 6. J Biol Chem. 2001. PMID: 11546803 Free PMC article. - Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA.
Coelho MA, de Carné Trécesson S, Rana S, Zecchin D, Moore C, Molina-Arcas M, East P, Spencer-Dene B, Nye E, Barnouin K, Snijders AP, Lai WS, Blackshear PJ, Downward J. Coelho MA, et al. Immunity. 2017 Dec 19;47(6):1083-1099.e6. doi: 10.1016/j.immuni.2017.11.016. Epub 2017 Dec 12. Immunity. 2017. PMID: 29246442 Free PMC article. - Fenretinide corrects the imbalance between omega-6 to omega-3 polyunsaturated fatty acids and inhibits macrophage inflammatory mediators via the ERK pathway.
Lachance C, Wojewodka G, Skinner TA, Guilbault C, De Sanctis JB, Radzioch D. Lachance C, et al. PLoS One. 2013 Sep 12;8(9):e74875. doi: 10.1371/journal.pone.0074875. eCollection 2013. PLoS One. 2013. PMID: 24069363 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases